Hedayat S, Cascione L, Cunningham D, Schirripa M, et al. Circulating microRNA analysis in a prospective co-clinical trial identifies MIR652-3p as a response biomarker and driver of regorafenib resistance mechanisms in colorectal cancer. Clin Cancer Res 2024 Feb 20. doi: 10.1158/1078-0432.CCR-23-2748.
PMID: 38376926